NO20052172L - 4-aminopiperidinderivater, fremgangsmate for deres fremstilling og deres anvendelse som medikamenter - Google Patents
4-aminopiperidinderivater, fremgangsmate for deres fremstilling og deres anvendelse som medikamenterInfo
- Publication number
- NO20052172L NO20052172L NO20052172A NO20052172A NO20052172L NO 20052172 L NO20052172 L NO 20052172L NO 20052172 A NO20052172 A NO 20052172A NO 20052172 A NO20052172 A NO 20052172A NO 20052172 L NO20052172 L NO 20052172L
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- drugs
- aminopiperidine derivatives
- derivatives
- compounds
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- BCIIMDOZSUCSEN-UHFFFAOYSA-N piperidin-4-amine Chemical class NC1CCNCC1 BCIIMDOZSUCSEN-UHFFFAOYSA-N 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 230000001430 anti-depressive effect Effects 0.000 abstract 1
- 239000000935 antidepressant agent Substances 0.000 abstract 1
- 229940005513 antidepressants Drugs 0.000 abstract 1
- 208000015114 central nervous system disease Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 208000027232 peripheral nervous system disease Diseases 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4465—Non condensed piperidines, e.g. piperocaine only substituted in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02022191 | 2002-10-04 | ||
| PCT/EP2003/010824 WO2004030668A1 (fr) | 2002-10-04 | 2003-09-30 | Derives de 4-aminopiperidine, procedes de preparation de ces derives et utilisation de ces derives comme medicaments |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20052172D0 NO20052172D0 (no) | 2005-05-03 |
| NO20052172L true NO20052172L (no) | 2005-06-30 |
Family
ID=32049973
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20052172A NO20052172L (no) | 2002-10-04 | 2005-05-03 | 4-aminopiperidinderivater, fremgangsmate for deres fremstilling og deres anvendelse som medikamenter |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US7488741B2 (fr) |
| EP (2) | EP1556045B1 (fr) |
| JP (1) | JP2006513151A (fr) |
| KR (1) | KR20050055748A (fr) |
| CN (1) | CN1688307A (fr) |
| AT (1) | ATE334680T1 (fr) |
| AU (1) | AU2003270291A1 (fr) |
| BR (1) | BR0314811A (fr) |
| CA (1) | CA2500664A1 (fr) |
| DE (1) | DE60307308T2 (fr) |
| DK (1) | DK1556045T3 (fr) |
| ES (1) | ES2268406T3 (fr) |
| MX (1) | MXPA05003290A (fr) |
| NO (1) | NO20052172L (fr) |
| NZ (1) | NZ539015A (fr) |
| PL (1) | PL376368A1 (fr) |
| PT (1) | PT1556045E (fr) |
| RU (1) | RU2005110409A (fr) |
| SI (1) | SI1556045T1 (fr) |
| WO (1) | WO2004030668A1 (fr) |
| ZA (1) | ZA200502330B (fr) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003290735A1 (en) * | 2002-12-06 | 2004-06-30 | Eli Lilly And Company | Inhibitors of monoamine uptake |
| ES2298782T3 (es) * | 2003-06-11 | 2008-05-16 | Eli Lilly And Company | 3-aminopirrolidinas como inhibidores de la reabsorcion de monoaminas. |
| WO2005053663A2 (fr) * | 2003-11-24 | 2005-06-16 | Eli Lilly And Company | Traitement de la defaillance cognitive |
| US7615648B2 (en) * | 2004-06-01 | 2009-11-10 | Eli Lilly And Company | Aminomethyl-azacycle derivatives as inhibitors of monoamine uptake |
| EP2968359B1 (fr) | 2013-03-12 | 2021-01-20 | Celltaxis, LLC | Procédés d'inhibition de la leucotriène a4 hydrolase |
| JP2016513681A (ja) * | 2013-03-14 | 2016-05-16 | セルタクシス，インコーポレイテッド | ロイコトリエンａ４加水分解酵素の阻害剤 |
| JP7386815B2 (ja) | 2018-05-31 | 2023-11-27 | セルタクシー、エルエルシー | 呼吸器疾患患者の肺増悪を軽減する方法 |
| CN111233751B (zh) * | 2020-03-25 | 2021-02-02 | 丽水绿氟科技有限公司 | 一种3,3-二氟-4-氨基哌啶类化合物及其衍生物的制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EG12406A (en) * | 1976-08-12 | 1979-03-31 | Janssen Pharmaceutica Nv | Process for preparing of novel n-aryl-n-(1-l-4-piperidinyl)-arylacetamides |
| JPH05148234A (ja) * | 1991-10-02 | 1993-06-15 | Hokuriku Seiyaku Co Ltd | アルカン酸誘導体 |
| DE4404183A1 (de) * | 1994-02-10 | 1995-08-17 | Merck Patent Gmbh | 4-Amino-1-piperidylbenzoylguanidine |
| GB0108876D0 (en) * | 2001-04-09 | 2001-05-30 | Novartis Ag | Organic Compounds |
-
2003
- 2003-09-30 US US10/528,924 patent/US7488741B2/en not_active Expired - Fee Related
- 2003-09-30 AU AU2003270291A patent/AU2003270291A1/en not_active Abandoned
- 2003-09-30 RU RU2005110409/04A patent/RU2005110409A/ru not_active Application Discontinuation
- 2003-09-30 SI SI200330506T patent/SI1556045T1/sl unknown
- 2003-09-30 PT PT03750658T patent/PT1556045E/pt unknown
- 2003-09-30 KR KR1020057005877A patent/KR20050055748A/ko not_active Application Discontinuation
- 2003-09-30 ES ES03750658T patent/ES2268406T3/es not_active Expired - Lifetime
- 2003-09-30 EP EP03750658A patent/EP1556045B1/fr not_active Expired - Lifetime
- 2003-09-30 JP JP2004540745A patent/JP2006513151A/ja active Pending
- 2003-09-30 BR BR0314811-4A patent/BR0314811A/pt not_active IP Right Cessation
- 2003-09-30 DE DE60307308T patent/DE60307308T2/de not_active Expired - Lifetime
- 2003-09-30 WO PCT/EP2003/010824 patent/WO2004030668A1/fr active IP Right Grant
- 2003-09-30 CA CA002500664A patent/CA2500664A1/fr not_active Abandoned
- 2003-09-30 AT AT03750658T patent/ATE334680T1/de not_active IP Right Cessation
- 2003-09-30 PL PL03376368A patent/PL376368A1/xx not_active Application Discontinuation
- 2003-09-30 EP EP06008607A patent/EP1693061A1/fr not_active Withdrawn
- 2003-09-30 NZ NZ539015A patent/NZ539015A/en unknown
- 2003-09-30 DK DK03750658T patent/DK1556045T3/da active
- 2003-09-30 MX MXPA05003290A patent/MXPA05003290A/es not_active Application Discontinuation
- 2003-09-30 CN CNA03823730XA patent/CN1688307A/zh active Pending
-
2005
- 2005-03-18 ZA ZA200502330A patent/ZA200502330B/en unknown
- 2005-05-03 NO NO20052172A patent/NO20052172L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004030668A1 (fr) | 2004-04-15 |
| AU2003270291A1 (en) | 2004-04-23 |
| MXPA05003290A (es) | 2005-07-05 |
| PL376368A1 (en) | 2005-12-27 |
| KR20050055748A (ko) | 2005-06-13 |
| EP1693061A1 (fr) | 2006-08-23 |
| ATE334680T1 (de) | 2006-08-15 |
| SI1556045T1 (sl) | 2007-02-28 |
| ZA200502330B (en) | 2006-05-31 |
| US7488741B2 (en) | 2009-02-10 |
| JP2006513151A (ja) | 2006-04-20 |
| BR0314811A (pt) | 2005-08-02 |
| RU2005110409A (ru) | 2005-09-10 |
| US20060128753A1 (en) | 2006-06-15 |
| ES2268406T3 (es) | 2007-03-16 |
| EP1556045B1 (fr) | 2006-08-02 |
| NZ539015A (en) | 2006-02-24 |
| EP1556045A1 (fr) | 2005-07-27 |
| DK1556045T3 (da) | 2006-11-27 |
| CN1688307A (zh) | 2005-10-26 |
| DE60307308D1 (de) | 2006-09-14 |
| NO20052172D0 (no) | 2005-05-03 |
| CA2500664A1 (fr) | 2004-04-15 |
| PT1556045E (pt) | 2006-12-29 |
| DE60307308T2 (de) | 2006-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20052172L (no) | 4-aminopiperidinderivater, fremgangsmate for deres fremstilling og deres anvendelse som medikamenter | |
| NO20072784L (no) | Pyridenkarboksamidderivater for anvendelse som anticancer midler | |
| NO20070067L (no) | Pyrrolopyridinderivater | |
| NO330888B1 (no) | Benzensylfonamidderivater, fremgangsmate for fremstilling av slike, terapeutisk preparatinneholdende slike samt anvendelse av slike for fremstilling av preparat for behandling av sykdom | |
| NO20055837L (no) | Immunsupprimerende forbindelser og sammensetninger | |
| NO20072548L (no) | Xantinderivater med HM74A reseptoraktivitet | |
| EA200601212A1 (ru) | Ингибиторы фосфодиэстеразы, получение и их терапевтическое применение | |
| NO20054414L (no) | Dihydropteridinoner, metoder for deres fremstilling og bruk av disse som medisiner | |
| BR0309875A (pt) | métodos e composições para tratamento de distúrbios do sistema nervoso periférico e novos compostos úteis para isto | |
| NO20055092L (no) | Substituerte pyrimidioner | |
| NO20055863L (no) | W-karboksyarylsubstituerte difenylureaforbindelser som raf-kinaseinhibitorer | |
| EA200602191A1 (ru) | 5,5-дизамещённые-2-амино-4-тиазолидиноны и способ их получения, фармацевтическая композиция и способ лечения | |
| NO991732L (no) | Nye heterocyklylmetylsubstituerte pyrazolderivater | |
| NO20082065L (no) | Nye imidazo[4,5-b]pyridinderivater som inhibitorer av glykogensyntasekinase 3 for anvendelse ved behandling av demens og neurodegenerative forstyrrelser | |
| NO20070199L (no) | Substituerte kinazoloner som anti-kreftmidler | |
| NO20070432L (no) | Pyrimidinureaderivater som kinaseinhibitorer | |
| NO20082709L (no) | Kjemiske forbindelser | |
| NO20054842L (no) | Kjemiske forbindelser | |
| MY140840A (en) | Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals | |
| NO20073876L (no) | Pyrazolopyrimidinderivater som mGluR2-antagonister | |
| HK1080459A1 (en) | Novel pyrimidineamide derivatives and the use thereof | |
| NO20070061L (no) | 3-beta-D-ribofuranosyltiazolo[4,5-d]pyridiminnukleosider og anvendelser derav | |
| NO20064974L (no) | terapeutiske midler | |
| DK0781281T3 (da) | Beta-Carbolinderivater som melatonin-agonister, fremgangsmåder til fremstilling deraf og deres anvendelse som lægemiddel | |
| NO20062824L (no) | 1,3-Difenylprop-2-en-1-on-avledete forbindelser, fremgangsmater for fremstilling derav, samt anvendelse av samme |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |